Skip to Main Content

Paper Details

Preclinical efficacy of hK2 targeted [Lu]hu11B6 for prostate cancer theranostics.
Theranostics
13
2019
177Lu, 225Ac, AR, AR protein, Actinium-225, Androgen, Ki-67, LNCaP, Lutetium-177, PCa, PCa xenografts, SA- -gal, SA--gal, Tumor, [177Lu, [177Lu], [177Lu]hu11B6, androgen, androgen receptor, blood cell, cells, hK2, hu11B6, human, human kallikrein 2, humanized IgG1 antibody hu11B6, men, metastatic prostate cancer, mice, mice kallikreins, myelotoxicity, prostate, prostate and prostate cancer (PCa) cells, prostate cancer, rodent, tumor, tumors, xenografts
Author NameAffiliation
Erik LarssonLund University
  • 1 - 1

Datasets

Release 1.2